A phase II study of the survivin suppressant YM155 in...

Cancer 2012 Vol. 118; Iss. 12

A phase II study of the survivin suppressant YM155 in patients with refractory diffuse large B-cell lymphoma

Bruce D. Cheson, Nancy L. Bartlett, Julie M. Vose, Andres Lopez-Hernandez, Amanda L. Seiz, Anne T. Keating, Setareh Shamsili
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
118
Year:
2012
Language:
english
Pages:
1
DOI:
10.1002/cncr.26510
File:
PDF, 232 KB
english, 2012
Conversion to is in progress
Conversion to is failed